Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1I.v. selexipag
(Uptravi (TN))		1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
2Observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi4件: Epoprostenol,
Iloprost,
Macitentan,
Selexipag (Uptravi)		4件: Epoprostenol ,
Iloprost ,
Selexipag (Uptravi (TN)),
Macitentan 💬 		3件: EDNRA,
EDNRB,
PTGIR 💬 		10件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Platelet activation, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
3Oral selexipag (Uptravi)1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
4SELEXIPAG
(Uptravi (TN))		1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬5件: 51, 70, 84, 86, 88 💬
5Selexipag (Uptravi)1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
6Selexipag, ACT-293987 (NS-304)
(Uptravi (TN))		1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
7Uptravi1件: Selexipag (Uptravi)1件: Selexipag (Uptravi (TN)) 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬3件: 84, 86, 88 💬